← Evidence map

ArticleTranslational andrology and urology2025

Balancing effectiveness, toxicity, and individualization: enfortumab vedotin in advanced urothelial cancer.

Nuowei Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

1 paper cites it

2025
2026
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 40226067